PEOPLE - AngioTech Pharmaceuticals makes appointment:
This article was originally published in Clinica
Canadian company AngioTech Pharmaceuticals has elected John McDermott, president of vascular products company IMPRA, to its board of directors. AngioTech develops medical device coatings and treatments for chronic inflammatory diseases.
You may also be interested in...
The AAM has insisted that the US Supreme Court should uphold the inter partes review framework, in an amicus brief filed as part of litigation that potentially threatens hundreds of IPR decisions.
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.